BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Sijl AM, Peters MJ, Knol DK, de Vet HC, Gonzalez-Gay MA, Smulders YM, Dijkmans BA, Nurmohamed MT. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum. 2011;40:389-397. [PMID: 20889191 DOI: 10.1016/j.semarthrit.2010.06.006] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Klimek E, Mikołajczyk T, Sulicka J, Kwaśny-Krochin B, Korkosz M, Osmenda G, Wizner B, Surdacki A, Guzik T, Grodzicki TK, Skalska A. Blood monocyte subsets and selected cardiovascular risk markers in rheumatoid arthritis of short duration in relation to disease activity. Biomed Res Int 2014;2014:736853. [PMID: 25126574 DOI: 10.1155/2014/736853] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
2 Profumo E, Di Franco M, Buttari B, Masella R, Filesi C, Tosti ME, Scrivo R, Scarno A, Spadaro A, Saso L. Biomarkers of subclinical atherosclerosis in patients with autoimmune disorders. Mediators Inflamm. 2012;2012:503942. [PMID: 22529523 DOI: 10.1155/2012/503942] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
3 Van Sijl AM, Van Den Hurk K, Peters MJ, Van Halm VP, Nijpels G, Stehouwer CD, Smulders YM, Voskuyl AE, Dekker JM, Nurmohamed MT. Different Type of Carotid Arterial Wall Remodeling in Rheumatoid Arthritis Compared with Healthy Subjects: A Case-Control Study. J Rheumatol 2012;39:2261-6. [DOI: 10.3899/jrheum.120617] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
4 Jednacz E, Rutkowska-Sak L. Atherosclerosis in juvenile idiopathic arthritis. Mediators Inflamm 2012;2012:714732. [PMID: 22933832 DOI: 10.1155/2012/714732] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
5 Södergren A, Karp K, Bengtsson C, Möller B, Rantapää-Dahlqvist S, Wållberg-Jonsson S. Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis? Biomed Res Int 2015;2015:673018. [PMID: 26504820 DOI: 10.1155/2015/673018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
6 Öhman M, Öhman ML, Wållberg-Jonsson S. The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis. Scand J Rheumatol 2014;43:259-64. [PMID: 24689997 DOI: 10.3109/03009742.2013.877158] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
7 Shen J, Shang Q, Tam L. Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis. Translational Research 2016;167:138-51. [DOI: 10.1016/j.trsl.2015.05.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
8 Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R, Spiegel B, McMahon M, Hahn B, Khanna D. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum. 2011;63:2078-2090. [PMID: 21480189 DOI: 10.1002/art.30380] [Cited by in Crossref: 108] [Cited by in F6Publishing: 73] [Article Influence: 10.8] [Reference Citation Analysis]
9 Södergren A, Karp K, Bengtsson C, Möller B, Rantapää-Dahlqvist S, Wållberg-Jonsson S. Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis. PLoS One 2019;14:e0220531. [PMID: 31381601 DOI: 10.1371/journal.pone.0220531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Temiz A, Gökmen F, Gazi E, Akbal A, Barutçu A, Bekler A, Altun B, Tan Y, Güneş F, Şen H. Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima–media thickness: Associations in rheumatoid arthritis patients. Herz 2015;40:217-24. [DOI: 10.1007/s00059-014-4140-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
11 Mackey RH, Kuller LH, Moreland LW. Cardiovascular Disease Risk in Patients with Rheumatic Diseases. Clin Geriatr Med 2017;33:105-17. [PMID: 27886692 DOI: 10.1016/j.cger.2016.08.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
12 Spinelli FR, Pecani A, Ciciarello F, Colasanti T, Di Franco M, Miranda F, Conti F, Valesini G, Alessandri C. Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients. BMC Musculoskelet Disord 2017;18:214. [PMID: 28545441 DOI: 10.1186/s12891-017-1563-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
13 Georgiadis AN, Pelechas E, Voulgari PV, Drosos AA. Correspondence on 'Cardiovascular effects of biological versus csDMARD therapy in treatment naive, early rheumatoid arthritis'. Ann Rheum Dis 2021:annrheumdis-2021-219891. [PMID: 33558259 DOI: 10.1136/annrheumdis-2021-219891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 del Rincón I, Polak JF, O'Leary DH, Battafarano DF, Erikson JM, Restrepo JF, Molina E, Escalante A. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis 2015;74:1118-23. [PMID: 24845391 DOI: 10.1136/annrheumdis-2013-205058] [Cited by in Crossref: 71] [Cited by in F6Publishing: 51] [Article Influence: 10.1] [Reference Citation Analysis]
15 López-mejías R, Castañeda S, González-juanatey C, Corrales A, Ferraz-amaro I, Genre F, Remuzgo-martínez S, Rodriguez-rodriguez L, Blanco R, Llorca J, Martín J, González-gay MA. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. Autoimmunity Reviews 2016;15:1013-30. [DOI: 10.1016/j.autrev.2016.07.026] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 14.2] [Reference Citation Analysis]
16 Raczkiewicz A, Juszkiewicz A, Kisiel B, Bachta A, Kur-Zalewska J, Kłos K, Bujakowska O, Tłustochowicz M, Tłustochowicz W. Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis. Arch Med Sci Atheroscler Dis 2016;1:e36-43. [PMID: 28905017 DOI: 10.5114/amsad.2016.60225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Veselinovic M, Jakovljevic V, Jurisic-Skevin A, Toncev S, Djuric DM. Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study. Clin Rheumatol 2012;31:1727-32. [PMID: 22960771 DOI: 10.1007/s10067-012-2079-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
18 Hinkema HJ, Nienhuis HL, de Groot L, Smit AJ, van Roon AM, Bijl M, Posthumus MD. Is Small Artery Elasticity Decreased Prior to Intima-Media Thickening in Patients with Longstanding Rheumatoid Arthritis? J Rheumatol 2011;38:2133-40. [DOI: 10.3899/jrheum.100989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
19 Caimmi C, De Marchi S, Bosello SL, Giuggioli D, Caramaschi P, Di Giorgio A, Spinella A, Astorino G, Canestrari G, Cocchiara E, Gremese E, Viapiana O, Rossini M. Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients. Int J Rheum Dis 2020;23:681-92. [DOI: 10.1111/1756-185x.13824] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Fragoulis GE, Panayotidis I, Nikiphorou E. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment. Curr Vasc Pharmacol 2020;18:431-46. [PMID: 31258091 DOI: 10.2174/1570161117666190619143842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
21 Dougados M. Comorbidities in rheumatoid arthritis. Current Opinion in Rheumatology 2016;28:282-8. [DOI: 10.1097/bor.0000000000000267] [Cited by in Crossref: 55] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
22 Gómez-Vaquero C, Corrales A, Zacarías A, Rueda-Gotor J, Blanco R, González-Juanatey C, Llorca J, González-Gay MA. SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis. Arthritis Res Ther 2013;15:R91. [PMID: 23965231 DOI: 10.1186/ar4271] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 3.9] [Reference Citation Analysis]
23 Coulson EJ, Ng W, Goff I, Foster HE. Cardiovascular risk in juvenile idiopathic arthritis. Rheumatology 2013;52:1163-71. [DOI: 10.1093/rheumatology/ket106] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
24 Dimitroulas T, Sandoo A, Hodson J, Smith JP, Kitas GD. In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort. Scand J Clin Lab Invest 2016;76:331-7. [PMID: 27166512 DOI: 10.1080/00365513.2016.1177852] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
25 Filippatos TD, Derdemezis CS, Voulgari PV, Tsimihodimos V, Elisaf MS, Tselepis AD, Drosos AA. Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study. Scand J Rheumatol 2013;42:169-75. [PMID: 23311768 DOI: 10.3109/03009742.2012.745013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
26 Mackey RH, Kuller LH, Moreland LW. Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases. Rheum Dis Clin North Am 2018;44:475-87. [PMID: 30001787 DOI: 10.1016/j.rdc.2018.03.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
27 Ikonomidis I, Makavos G, Katsimbri P, Boumpas DT, Parissis J, Iliodromitis E. Imaging Risk in Multisystem Inflammatory Diseases. JACC: Cardiovascular Imaging 2019;12:2517-37. [DOI: 10.1016/j.jcmg.2018.06.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
28 Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford) 2014;53:2143-54. [PMID: 24907149 DOI: 10.1093/rheumatology/keu224] [Cited by in Crossref: 163] [Cited by in F6Publishing: 126] [Article Influence: 23.3] [Reference Citation Analysis]
29 Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Tremoli E. Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies. Eur J Intern Med 2015;26:835-42. [PMID: 26547241 DOI: 10.1016/j.ejim.2015.10.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
30 Serhal M, Longenecker CT. Preventing Heart Failure in Inflammatory and Immune Disorders. Curr Cardiovasc Risk Rep 2014;8:392. [PMID: 26316924 DOI: 10.1007/s12170-014-0392-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
31 Taverner D, Vallvé JC, Ferré R, Paredes S, Masana L, Castro A. Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age. PLoS One 2018;13:e0193690. [PMID: 29494666 DOI: 10.1371/journal.pone.0193690] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 González-Juanatey C, Llorca J, González-Gay MA. Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. Arthritis Res Ther 2011;13:R101. [PMID: 21696620 DOI: 10.1186/ar3382] [Cited by in Crossref: 82] [Cited by in F6Publishing: 34] [Article Influence: 8.2] [Reference Citation Analysis]
33 Erhayiem B, Pavitt S, Baxter P, Andrews J, Greenwood JP, Buch MH, Plein S. Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial. Trials 2014;15:436. [PMID: 25381560 DOI: 10.1186/1745-6215-15-436] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
34 Castañeda S, Nurmohamed MT, González-gay MA. Cardiovascular disease in inflammatory rheumatic diseases. Best Practice & Research Clinical Rheumatology 2016;30:851-69. [DOI: 10.1016/j.berh.2016.10.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 11.4] [Reference Citation Analysis]
35 Kisiel B, Kruszewski R, Juszkiewicz A, Raczkiewicz A, Bachta A, Tłustochowicz M, Staniszewska-Varga J, Kłos K, Duda K, Bogusławska-Walecka R, Płoski R, Tłustochowicz W. Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis. J Immunol Res 2015;2015:759610. [PMID: 26090499 DOI: 10.1155/2015/759610] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
36 Bonek K, Głuszko P. Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approach. Reumatologia 2016;54:128-35. [PMID: 27504023 DOI: 10.5114/reum.2016.61214] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
37 López-Mejías R, Genre F, García-Bermúdez M, Corrales A, González-Juanatey C, Llorca J, Miranda-Filloy JA, Rueda-Gotor J, Blanco R, Castañeda S, Martín J, González-Gay MA. The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis. Arthritis Res Ther 2013;15:R152. [PMID: 24286297 DOI: 10.1186/ar4335] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
38 Södergren A, Karp K, Bengtsson C, Möller B, Rantapää-dahlqvist S, Wållberg-jonsson S. The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls. J Rheumatol 2015;42:935-42. [DOI: 10.3899/jrheum.140694] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
39 Crowson CS, Gabriel SE. Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 2011;70:719-21. [PMID: 21345812 DOI: 10.1136/ard.2010.145482] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
40 Tam LS, Kitas GD, González-Gay MA. Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology (Oxford) 2014;53:1108-19. [PMID: 24501245 DOI: 10.1093/rheumatology/ket454] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 9.7] [Reference Citation Analysis]
41 Ferraz-Amaro I, Corrales A, Quevedo-Abeledo JC, Vegas-Revenga N, Blanco R, Portilla V, Atienza-Mateo B, González-Gay MÁ. Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk. Arthritis Res Ther 2021;23:162. [PMID: 34088356 DOI: 10.1186/s13075-021-02542-7] [Reference Citation Analysis]
42 Machado-Silva W, Henriques AD, Souza GD, Gomes L, Ferreira AP, Brito CJ, Córdova C, Moraes CF, Nóbrega OT. Serum Immune Mediators Independently Associate with Atherosclerosis in the Left (But Not Right) Carotid Territory of Older Individuals. J Stroke Cerebrovasc Dis 2016;25:2851-8. [PMID: 27554076 DOI: 10.1016/j.jstrokecerebrovasdis.2016.07.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
43 Wang P, Guan SY, Xu SZ, Li HM, Leng RX, Li XP, Pan HF. Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis. Clin Rheumatol 2016;35:315-23. [PMID: 26614535 DOI: 10.1007/s10067-015-3130-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
44 Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH, Torp-Pedersen C, Hansen PR. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ. 2012;344:e1257. [PMID: 22403267 DOI: 10.1136/bmj.e1257] [Cited by in Crossref: 104] [Cited by in F6Publishing: 82] [Article Influence: 11.6] [Reference Citation Analysis]
45 Bissell LA, Erhayiem B, Fent G, Hensor EMA, Burska A, Donica H, Plein S, Buch MH, Greenwood JP, Andrews J. Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study. Arthritis Res Ther 2018;20:266. [PMID: 30509325 DOI: 10.1186/s13075-018-1761-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
46 Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MND. Subclinical atherosclerosis in patients with rheumatoid arthritis: A meta-analysis of literature studies. Thromb Haemost 2017;113:916-30. [DOI: 10.1160/th14-11-0921] [Cited by in Crossref: 80] [Cited by in F6Publishing: 26] [Article Influence: 20.0] [Reference Citation Analysis]
47 Asquith DL, Ballantine LE, Nijjar JS, Makdasy MK, Patel S, Wright PB, Reilly JH, Kerr S, Kurowska-Stolarska M, Gracie JA, McInnes IB. The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release. Ann Rheum Dis 2013;72:2024-31. [PMID: 23434566 DOI: 10.1136/annrheumdis-2012-202872] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
48 Gómez-Vaquero C, Robustillo M, Narváez J, Rodríguez-Moreno J, González-Juanatey C, Llorca J, Nolla JM, González-Gay MA. Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index. Clin Rheumatol 2012;31:35-9. [PMID: 21567119 DOI: 10.1007/s10067-011-1774-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
49 Mitrović J, Morović-vergles J, Horvatić I, Badžak J, Stojić M, Gamulin S. Ambulatory arterial stiffness index and carotid intima-media thickness in hypertensive rheumatoid patients: a comparative cross-sectional study. Int J Rheum Dis 2017;20:1998-2002. [DOI: 10.1111/1756-185x.12613] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
50 Kurmann RD, Mankad R. Atherosclerotic vascular disease in the autoimmune rheumatologic woman. Clin Cardiol 2018;41:258-63. [PMID: 29480591 DOI: 10.1002/clc.22916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
51 Végh E, Kerekes G, Pusztai A, Hamar A, Szamosi S, Váncsa A, Bodoki L, Pogácsás L, Balázs F, Hodosi K, Domján A, Szántó S, Nagy Z, Szekanecz Z, Szűcs G. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis. Rheumatol Int 2020;40:427-36. [DOI: 10.1007/s00296-019-04497-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
52 Oláh C, Kardos Z, Sepsi M, Sas A, Kostyál L, Bhattoa HP, Hodosi K, Kerekes G, Tamási L, Valikovics A, Bereczki D, Szekanecz Z. Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis. Arthritis Res Ther 2017;19:213. [PMID: 28950911 DOI: 10.1186/s13075-017-1422-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
53 Soubrier M, Chamoux NB, Tatar Z, Couderc M, Dubost J, Mathieu S. Cardiovascular risk in rheumatoid arthritis. Joint Bone Spine 2014;81:298-302. [DOI: 10.1016/j.jbspin.2014.01.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
54 Naredo E, Moller I, Corrales A, Bong DA, Cobo-ibanez T, Corominas H, Garcia-vivar ML, Macarron P, Navio T, Richi P, Iagnocco A, Garrido J, Martinez-hernandez D. Automated radiofrequency-based US measurement of common carotid intima-media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs. Rheumatology 2013;52:376-81. [DOI: 10.1093/rheumatology/kes260] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
55 Arida A, Zampeli E, Konstantonis G, Fragiadaki K, Kitas GD, Protogerou AD, Sfikakis PP. Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors. Clin Rheumatol 2015;34:853-9. [PMID: 25754335 DOI: 10.1007/s10067-015-2914-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
56 Burggraaf B, van Breukelen – van der Stoep DF, de Vries MA, Klop B, van Zeben J, van de Geijn GM, van der Meulen N, Birnie E, Prinzen L, Castro Cabezas M. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome. Atherosclerosis 2018;271:84-91. [DOI: 10.1016/j.atherosclerosis.2018.02.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Liao KP. Cardiovascular disease in patients with rheumatoid arthritis. Trends Cardiovasc Med 2017;27:136-40. [PMID: 27612551 DOI: 10.1016/j.tcm.2016.07.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
58 Martín-martínez MA, González-juanatey C, Castañeda S, Llorca J, Ferraz-amaro I, Fernández-gutiérrez B, Díaz-gonzález F, González-gay MA. Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion. Seminars in Arthritis and Rheumatism 2014;44:1-8. [DOI: 10.1016/j.semarthrit.2014.01.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
59 Abd El-Aziz TA, Mohamed RH. Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis. Gene 2017;610:127-32. [PMID: 28215593 DOI: 10.1016/j.gene.2017.02.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
60 Chighizola CB, Favalli EG, Meroni PL. Novel mechanisms of action of the biologicals in rheumatic diseases. Clin Rev Allergy Immunol 2014;47:6-16. [PMID: 23345026 DOI: 10.1007/s12016-013-8359-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
61 Hamdi W, Chelli Bouaziz M, Zouch I, Ghannouchi MM, Haouel M, Ladeb MF, Kchir MM. Assessment of preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol 2012;39:322-6. [PMID: 22247364 DOI: 10.3899/jrheum.110792] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
62 Furer V, Fayad ZA, Mani V, Calcagno C, Farkouh ME, Greenberg JD. Noninvasive Cardiovascular Imaging in Rheumatoid Arthritis: Current Modalities and the Emerging Role of Magnetic Resonance and Positron Emission Tomography Imaging. Seminars in Arthritis and Rheumatism 2012;41:676-88. [DOI: 10.1016/j.semarthrit.2011.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
63 Scarno A, Perrotta FM, Cardini F, Carboni A, Annibali G, Lubrano E, Spadaro A. Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis. World J Orthop 2014;5:328-35. [PMID: 25035836 DOI: 10.5312/wjo.v5.i3.328] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
64 John H, Toms TE, Kitas GD. Rheumatoid arthritis: is it a coronary heart disease equivalent? Curr Opin Cardiol 2011;26:327-33. [PMID: 21499088 DOI: 10.1097/HCO.0b013e32834703b5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
65 Santovito D, Weber C. Atherosclerosis revisited from a clinical perspective: still an inflammatory disease? Thromb Haemost 2017;117:231-7. [PMID: 27975102 DOI: 10.1160/TH16-10-0770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
66 Abdelmaboud NM, Elsaid HH. Endothelial dysfunction and subclinical atherosclerosis as evidenced by the measurement of flow mediated dilatation of brachial artery and carotid intima media thickness in patients with rheumatoid arthritis. The Egyptian Journal of Radiology and Nuclear Medicine 2013;44:237-43. [DOI: 10.1016/j.ejrnm.2012.12.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
67 Corrales A, González-Juanatey C, Peiró ME, Blanco R, Llorca J, González-Gay MA. Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 2014;73:722-7. [PMID: 23505241 DOI: 10.1136/annrheumdis-2012-203101] [Cited by in Crossref: 132] [Cited by in F6Publishing: 97] [Article Influence: 16.5] [Reference Citation Analysis]
68 Gkaliagkousi E, Gavriilaki E, Doumas M, Petidis K, Aslanidis S, Stella D. Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol 2012;18:422-30. [PMID: 23188207 DOI: 10.1097/RHU.0b013e31827846b1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
69 Metsios GS, Stavropoulos-kalinoglou A, Veldhuijzen van Zanten JJ, Nightingale P, Sandoo A, Dimitroulas T, Kitas GD, Koutedakis Y. Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis 2014;73:748-51. [DOI: 10.1136/annrheumdis-2013-203291] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 8.4] [Reference Citation Analysis]
70 Khanna NN, Jamthikar AD, Gupta D, Piga M, Saba L, Carcassi C, Giannopoulos AA, Nicolaides A, Laird JR, Suri HS, Mavrogeni S, Protogerou AD, Sfikakis P, Kitas GD, Suri JS. Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization. Curr Atheroscler Rep 2019;21:7. [PMID: 30684090 DOI: 10.1007/s11883-019-0766-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
71 Sahari NS, Shaharir SS, Ismail MR, Rajalingham S, Mohamed Said MS. Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors. Modern Rheumatology 2014;24:920-5. [DOI: 10.3109/14397595.2014.891497] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
72 Dessein PH, Woodiwiss AJ, Norton GR, Solomon A. Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study. Arthritis Res Ther 2013;15:R96. [PMID: 23968456 DOI: 10.1186/ar4276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]